5 results
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Total dose should ... respiratory tract infection ... anti-IL6 mAb) #AntiIL6 ... Siltuximab #COVID19 #Pharmacology ... #Management #Medications
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... ., concomitant medications ... ) for 1–4 doses ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
IDSA Recommendations ... Indications: ... (Varivax™), 2 doses ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... murmur 3/6) - Pulmonary ... Skin exam for infection ... Diabetes regimen ... medical and surgical management
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... months or • RFB (dose ... Tuberculosis #TB #IDSA ... Prevention #Treatment #management ... #HIVAIDS #pharmacology